FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387420009: Cyclophosphamide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461598019 Cyclophosphamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481512014 Cyclophosphamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492061017 CPM en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
1492062012 CTX en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
1492063019 CYT en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4842841000005117 cyclophosphamid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4842851000005115 cyclophosfamid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4842861000005118 cyclophosphamid, vandfrit da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclophosphamide (substance) Is a Nitrogen mustard derivative (substance) true Inferred relationship Some
Cyclophosphamide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alkylating agent (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental cyclophosphamide poisoning Causative agent False Cyclophosphamide (substance) Inferred relationship Some
Intentional cyclophosphamide poisoning Causative agent False Cyclophosphamide (substance) Inferred relationship Some
forgiftning med cyclophosphamid, uvist med hvilken hensigt Causative agent False Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide adverse reaction (disorder) Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Allergy to cyclophosphamide (finding) Causative agent False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide overdose Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Accidental cyclophosphamide overdose Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Intentional cyclophosphamide overdose Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
overdosis af cyclophosphamid, uvist med hvilken hensigt Causative agent False Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 200 mg pulver til infusionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 50 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 100mg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 200mg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 500mg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 1g/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 2 g/hætteglas injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 100 mg pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 1000 mg hætteglas injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Product containing cyclophosphamide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
Poisoning by cyclophosphamide Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Product containing cyclophosphamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
cyclophosphamid 200 mg/hætteglas pulver til injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 1g/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 500mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 2 g/pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 500 mg pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some
Accidental cyclophosphamide poisoning Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Intentional cyclophosphamide poisoning Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Allergy to cyclophosphamide (finding) Causative agent True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide therapy (procedure) Direct substance True Cyclophosphamide (substance) Inferred relationship Some 2
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) Direct substance True Cyclophosphamide (substance) Inferred relationship Some 8
Cyclophosphamide monohydrate (substance) Is a False Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Cyclophosphamide (substance) Inferred relationship Some
Cyclophosphamide 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
cyclophosphamid 2 g/pulver til injektionsvæske, hætteglas This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Cyclophosphamide (substance) Inferred relationship Some 1
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Cyclophosphamide (substance) Inferred relationship Some 1
cyclophosphamid 200 mg pulver til infusionsvæske, opløsning, hætteglas This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Cyclophosphamide (substance) Inferred relationship Some 1
cyclophosphamid 500 mg pulver til injektionsvæske, opløsning, hætteglas This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Cyclophosphamide (substance) Inferred relationship Some 1
Product containing only cyclophosphamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
Product containing only cyclophosphamide in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cyclophosphamide (substance) Inferred relationship Some 1
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy Direct substance True Cyclophosphamide (substance) Inferred relationship Some 5
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 200 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 200 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 500 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 500 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 1 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide 1 g powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclophosphamide (substance) Inferred relationship Some 1
Cyclophosphamide anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Cyclophosphamide (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start